We are live on
!
Find out more
TD Asset Management Portfolio holdings
AUM
$115B
1-Year Est. Return
41.58%
This Fund
S&P 500
This Quarter
Est. Return
-5.54%
1 Year Est. Return
+41.58%
3 Year Est. Return
+119.77%
5 Year Est. Return
+143.7%
10 Year Est. Return
+448.76%
AUM
$79.9B
AUM Growth
-$6.45B
(-7.5%)
Cap. Flow
-$1.92B
Cap. Flow
% of AUM
-2.4%
Top 10 Holdings %
Top 10 Hldgs %
28.59%
Holding
1,534
New
77
Increased
494
Reduced
709
Closed
60
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$128M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$124M |
| 3 |
Broadridge
BR
|
+$105M |
| 4 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$101M |
| 5 |
Motorola Solutions
MSI
|
+$94.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Atlassian
TEAM
|
+$332M |
| 2 |
NVIDIA
NVDA
|
+$268M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$190M |
| 4 |
TSMC
TSM
|
+$149M |
| 5 |
Cisco
CSCO
|
+$138M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.97% |
| 2 | Technology | 17.33% |
| 3 | Healthcare | 10.95% |
| 4 | Consumer Discretionary | 9% |
| 5 | Industrials | 7.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1351
Stoke Therapeutics
STOK
$1.99B
| $341K | ﹤0.01% |
26,186
-8,528
| -25% | -$136K |
|
1352
ProPetro Holding
PUMP
$1.37B
| $339K | ﹤0.01% |
+42,400
| New | +$379K |
|
1353
Teladoc Health
TDOC
$1.26B
| $337K | ﹤0.01% |
12,856
-278
| -2% | -$9.75K |
|
1354
National Presto Industries
NPK
$985M
| $335K | ﹤0.01% |
5,200
| – | – |
|
1355
Regenxbio
RGNX
$683M
| $335K | ﹤0.01% |
13,441
| – | – |
|
1356
Chewy
CHWY
$9.81B
| $332K | ﹤0.01% |
10,684
+200
| +2% | +$7.94K |
|
|
WHWK
1357
Whitehawk Therapeutics
WHWK
$210M
| $330K | ﹤0.01% |
24,083
| – | – |
|
|
PFHD
1358
DELISTED
Professional Holding Corp. Class A Common stock
PFHD
| $327K | ﹤0.01% |
12,468
-15,584
| -56% | -$397K |
|
1359
Louisiana-Pacific
LPX
$5.4B
| $326K | ﹤0.01% |
6,400
-4,600
| -42% | -$261K |
|
1360
Voyager Therapeutics
VYGR
$189M
| $326K | ﹤0.01% |
54,300
| – | – |
|
|
TBRG
1361
DELISTED
TruBridge
TBRG
| $322K | ﹤0.01% |
11,500
| – | – |
|
1362
Credit Acceptance
CACC
$6.36B
| $315K | ﹤0.01% |
715
-17
| -2% | -$8.97K |
|
1363
Alector
ALEC
$168M
| $312K | ﹤0.01% |
32,969
-6,900
| -17% | -$74.6K |
|
1364
Genesco
GCO
$444M
| $309K | ﹤0.01% |
+7,700
| New | +$411K |
|
1365
Simply Good Foods
SMPL
$1B
| $308K | ﹤0.01% |
+9,600
| New | +$315K |
|
|
RETA
1366
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $299K | ﹤0.01% |
11,936
| – | – |
|
1367
Middleby
MIDD
$6.15B
| $298K | ﹤0.01% |
+2,288
| New | +$321K |
|
|
SVM
1368
Silvercorp Metals
SVM
$2.42B
| $298K | ﹤0.01% |
132,868
-24,022
| -15% | -$57.8K |
|
1369
Provident Financial Services
PFS
$3.29B
| $288K | ﹤0.01% |
14,500
-36,300
| -71% | -$848K |
|
|
HIBB
1370
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $288K | ﹤0.01% |
+5,600
| New | +$294K |
|
1371
Caleres
CAL
$493M
| $286K | ﹤0.01% |
+11,500
| New | +$304K |
|
1372
Senti Biosciences Holdings
SNTI
$12.1M
| $285K | ﹤0.01% |
13,489
+4,719
| +54% | +$93K |
|
1373
Yelp
YELP
$1.47B
| $284K | ﹤0.01% |
+8,400
| New | +$278K |
|
1374
Applovin
APP
$144B
| $282K | ﹤0.01% |
14,322
+514
| +4% | +$15.4K |
|
1375
Design Therapeutics
DSGN
$827M
| $274K | ﹤0.01% |
16,318
-7,300
| -31% | -$145K |
|
Similar funds
VAM
TD Asset Management's Q3 2022 Portfolio in Review
As of Q3 2022, TD Asset Management held 1,534 positions worth $79.9B, down 7.5% from $86.3B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
TD Asset Management's Q3 2022 filing shows 77 new, 494 increased, 709 reduced and 60 closed positions. Its largest new stake was Eagle Materials: 154,517 shares worth $16.4M. The largest sale was Atlassian, an estimated $332M.
By sector, the portfolio is most concentrated in Financials at 20% of assets, down from 20% a quarter earlier, followed by Technology and Healthcare.
- TD Asset Management's largest Q3 2022 buy was Eagle Materials: 154,517 shares worth $16.4M.
- TD Asset Management added most to Thermo Fisher Scientific in Q3 2022, an estimated $128M increase.
- TD Asset Management's biggest Q3 2022 reduction was NVIDIA, cutting an estimated $268M.
- TD Asset Management fully exited Atlassian in Q3 2022, selling an estimated $332M.
- TD Asset Management's ten largest holdings make up 29% of its $79.9B portfolio in Q3 2022.
- TD Asset Management opened 77 new positions and closed 60 in Q3 2022.
- TD Asset Management's portfolio value fell 7.5% quarter-over-quarter to $79.9B.
Based on TD Asset Management's 13F filing for Q3 2022, filed 7 Nov 2022.